Three-dimensional analysis of abnormal ultrastructural alteration in mitochondria of hippocampus of APP/PSEN1 transgenic mouse

Journal of Biosciences

Volumn 39, Issue 1, 2014, Pages 97-105

  Choi, Ki Ju ^a,b   Kim, Mi Jeong ^a   Je, A Reum ^a   Jun, Sangmi ^a   Lee, Chulhyun ^a   Lee, Eunji ^c   Jo, Mijung ^c   Huh, Yang Hoon ^a   Kweon, Hee Seok ^a  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

3 D tomography; Alzheimer's disease; amyloid ; HVEM; mitochondria

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PEROXIREDOXIN 3;

ABNORMALITY; CELL ORGANELLE; MENTAL HEALTH; MITOCHONDRION; PATHOGENICITY; PERFORMANCE ASSESSMENT; PROTEIN; RODENT; THREE-DIMENSIONAL MODELING; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN MITOCHONDRION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON TOMOGRAPHY; HIPPOCAMPUS; IMMUNOGOLD ELECTRON MICROSCOPY; MOUSE; NEURITE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE; WILD TYPE;

MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ELECTRON MICROSCOPE TOMOGRAPHY; HIPPOCAMPUS; IMAGING, THREE-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; MITOCHONDRIA; NEURITES; PEROXIREDOXIN III; PRESENILIN-1;

EID: 84896049285     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-013-9406-8     Document Type: Article

References (33)

1. Abdelwahid E, Yokokura T, Krieser RJ, Balasundaram S, Fowle WH and White K 2007 Mitochondrial disruption in Drosophila apoptosis. Dev. Cell 12 793-806 (Pubitemid 46667748)
2. Anandatheerthavarada HK, Biswas G, Robin MA and Avadhani NG 2003 Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161 41-54 (Pubitemid 36459078)
3. Balietti M, Giorgetti B, Casoli T, Solazzi M, Tamagnini F, Burattini C, Aicardi G and Fattoretti P 2013 Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease. J. Alzheimers Dis. 34 887-896
4. Baloyannis SJ 2006 Mitochondrial alterations in Alzheimer's disease. J. Alzheimers Dis. 9 119-126 (Pubitemid 44088243)
5. Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ and Holtzman DM 2008 Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321 1221-1224
6. Chi V and Chandy KG 2007 Immunohistochemistry: paraffin sections using the Vectastain ABC kit from vector labs. J. Vis. Exp. 8 308
7. Du H, Guo L, Fang F, Chen D, Sosunov AA, Mckhann GM, Yan Y, Wang C, et al. 2008 Cyclophilin D deficiency attenuates mitochondrial and neural perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med. 14 1097-1105
8. Hattori F, Murayama N, Noshita T and Oikawa S. 2003 Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J. Neurochem. 86 860-868 (Pubitemid 36988798)
9. Hirai K, Aliev G, Nunomura A, Fujioka H, Russel RL, Atwood CS, Johnson AB and Kress Y et al. 2001 Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 3017-3023 (Pubitemid 32323483)
10. Hughes DE, Stolz DB, Yu S, Tan Y, Reddy JK, Watkins SC, Diehl AM and Costa RH 2003 Elevated hepatocyte levels of the forkhead box A2 (HNF-3β) transcription factor cause postnatal steanosis and mitochondrial damage. Hepatology 37 1414-1424 (Pubitemid 36667322)
11. Kaasik A, Safiulina D, Zharkovsky A and Veksler V 2007 Regulation of mitochondrial matrix volume. Am. J. Physiol. Cell Physiol. 292 157-163
12. Kann O and Kovacs R 2007 Mitochondria and neuronal activity. Am. J. Physiol. Cell Physiol. 292 641-657
13. Kang JE, Lim MM, Bateman RJ, Lee JJ, Symth LP, Cirrito JR, Fujiki N, Nishino S, et al. 2009 Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326 1005-1007
14. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Müller-Spahn F, Haass C, et al. 2004 Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J. Biol. Chem. 279 50310-50320 (Pubitemid 39577847)
15. 2-dependent, reversible inactivation of peroxiredoxin III in mitochondria. Mol. Cell 46 584-594
16. Kim MJ, Huh YH, Choi KJ, Jun S, Je AR, Chae H, Lee C and Kweon HS 2012 Ultrastructural abnormalities in APP/PSEN1 transgenic mouse brain as the Alzheimer's disease model. Appl. Microsc. 42 179-185
17. Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM and Knuesel I 2010 Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J. Neurosci. 30 9228-9240
18. Kremer JR, Mastronarde DN and Mclntosh J 1996 Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116 71-76 (Pubitemid 26093126)
19. Lijnen PJ, Piccart Y, Coenen T and Prihadi JS 2012 Angiotensin II-induced mitochondrial reactive oxygen species and peroxiredoxin-3 expression in cardiac fibroblasts. J. Hypertens. 30 1986-1991
20. Lin MT and Beal MF 2006 Alzheimer's APP mangles mitochondria. Nat. Med. 12 1241-1243 (Pubitemid 44706922)
21. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH and Park B et al. 2010 Mitochondria-targeted antioxidants protect against Abeta toxicity in Alzheimer's disease neurons. J. Alzheimers Dis. 20 609-631
22. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J and Reddy PH 2006 Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15 1437-1449
23. Mao P and Reddy PH 2011 Aging and amyloid beta-induced oxidative DNA damage and mitochodrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. Biochim. Biophys. Acta 1812 1359-1370
24. Moreira PI, Duarte AI, Santos MS, Rego AC and Oliveira CR 2009 An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J. Alzheimers Dis. 16 741-761
25. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A and Cuervo AM 2005 Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64 113-122 (Pubitemid 40349309)
26. Petersen CAH, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V and Ito A et al. 2008 The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial critae. Proc. Natl. Acad. Sci. USA 105 13145-13150
27. Piaceri I, Rinnochi V, Bagnoli S, Failli Y and Sorbi S 2012 Mitochondria and Alzheimer's disease. J. Neurol. Sci. 322 31-34
28. Reddy PH 2009 Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp. Neurol. 218 286-292
29. Reddy PH and Beal MF 2008 Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14 45-53
30. Selkoe DJ 2001 Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 741-766 (Pubitemid 32267077)
31. Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, Miller SW, Davis RE and Parker WD Jr 2000 Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp. Neurol. 162 37-50 (Pubitemid 30170099)
32. Umeda T, Tomiyama T, Sakama N, Tanaka S, Lambert MP, Klein WL and Mori H 2011 Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo. J. Neurosci. Res. 89 1031-1042
33. 2 accumulation for cell signalling. Cell 140 517-528